Beyond breathing: could an asthma drug lift emotional burdens for patients and partners?

NCT ID NCT04680611

First seen Jul 13, 2026 · Last updated Jul 14, 2026 · Updated 1 time

Summary

This study looks at how mepolizumab (Nucala), a treatment for severe eosinophilic asthma, impacts emotions and mental well-being in patients and their partners. Researchers will track changes in feelings like anxiety, depression, and stress using questionnaires and interviews. The goal is to understand the broader psychological effects of this therapy beyond just lung function.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
mepolizumab (Nucala)
What this could lead to
If successful, this could reveal how a biologic treatment for severe asthma improves emotional health and quality of life for patients and their partners.
What could go wrong
This is an observational study, not a controlled trial, so it cannot prove cause and effect. Results may not apply to all asthma patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADJUSTMENT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Department of Respiratory Medicine, Aberdeen Royal Infirmary

    Aberdeen, Grampian, AB25 2ZN, United Kingdom

  • Glasgow Gartnavel General Hospital

    Glasgow, G12 0YN, United Kingdom

  • Hull University Teaching Hospitals NHS Trust

    Hull, Yorkshire, HU16 5JQ, United Kingdom

  • Judit Varkonyi-Sepp

    Southampton, Hampshire, SO166YD, United Kingdom

  • Pinderfields Hospital

    Wakefield, Yorkshire, WF1 4DG, United Kingdom

  • Portsmouth Hospitals NHS Trust

    Portsmouth, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.